KoKa Life Sciences to Showcase KOKACLIP® and PIONEER-TAVR® at CMC Week 2025 in Quanzhou

When the coral trees blossom in the warm autumn sun of southern Fujian, Quanzhou — this ancient city that carries a millennium of Maritime Silk Road civilization — is embracing the global wave of medical innovation with an open posture. Recognized by UNESCO as the "starting point of the Maritime Silk Road," Quanzhou is a place where diverse cultures converge, and at the same time, the gene of innovation runs deep in the veins of this city.October 20-26, 2025, which has attracted widespread attention in the global cardiovascular field2025China Minimally Invasive Cardiovascular Surgery Conference (CMC) and International Minimally Invasive Cardiac Surgery Live Broadcast Week, grandly opened on this land that combines historical richness with contemporary vitality.

Kokai (Nantong) Life Sciences Co., Ltd., an innovative company in the field of structural heart disease, presented its independently developedKOKACLIP® Transcatheter Mitral Valve Repair SystemAndPIONEER-TAVR® Transcatheter Self-Expanding Aortic Valve System, Heavyweight Participation.

KOKACLIP® Transcatheter Mitral Valve Repair System achieves precise repair through minimally invasive technology, allowing high-risk patients to safely receive treatment, recover quickly after surgery, and enjoy a high-quality life; while PIONEER-TAVR® Transcatheter Self-Expanding Aortic Valve System is suitable for targeted treatment of pure aortic regurgitation.

Time

October 25-26, 2025

Location

3rd Floor, Quanzhou Taihe InterContinental Hotel

Kokai Booth

A19